Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

VIBATIV Pregnancy Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Theravance Biopharma Antibiotics, Inc.
Sponsor:
Information provided by (Responsible Party):
Theravance Biopharma Antibiotics, Inc.
ClinicalTrials.gov Identifier:
NCT01130324
First received: May 24, 2010
Last updated: June 24, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)